Catalyst Pharmaceuticals Inc

+0.12 (+2.02%)
Earnings Announcements

Catalyst Pharmaceuticals Posts Q4 EPS Of $0.11

Published: 03/15/2021 21:42 GMT
Catalyst Pharmaceuticals Inc (CPRX) - Catalyst Pharmaceuticals Announces Fourth Quarter and Year-end 2020 Financial Results and Provides Corporate Update.
Q4 Earnings per Share $0.11.
Q4 Earnings per Share Estimate $0.09 -- Refinitiv Ibes Data (analyst estimates).
Q4 Revenue $31 Million Versus Refinitiv Ibes Estimate of $30.4 Million.
Q4 Non-GAAP Earnings per Share $0.12 Excluding Items.
Catalyst Pharmaceuticals- at Dec 31, 2020, Co Had Cash and Cash Equivalents and Investments of $140.3 Million and No Funded Debt.
Revenue is expected to be $34.59 Million
Adjusted EPS is expected to be $0.10

Next Quarter Revenue Guidance is expected to be $35.85 Million
Next Quarter EPS Guidance is expected to be $0.11

More details on our Analysts Page.